Chemoinformaics analysis of 4-[2-Hydroxy-3-(4-hydroxyphenyl)propyl]phenol
| Molecular Weight | 244.29 | nRot | 4 |
| Heavy Atom Molecular Weight | 228.162 | nRig | 18 |
| Exact Molecular Weight | 244.11 | nRing | 2 |
| Solubility: LogS | -2.231 | nHRing | 0 |
| Solubility: LogP | -0.644 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 2 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 34 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 18 | No. of Aromatic Carbocycles | 2 |
| nHetero | 3 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 16 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 15 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 12 |
| No. of Oxygen atom | 3 | No. of Arom Bond | 12 |
| nHA | 3 | APOL | 38.1247 |
| nHD | 3 | BPOL | 16.0513 |
| QED | 0.437 |
| Synth | 3.963 |
| Natural Product Likeliness | 1.541 |
| NR-PPAR-gamma | 0.013 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.002 |
| Pgp-sub | 0.337 |
| HIA | 0.729 |
| CACO-2 | -5.728 |
| MDCK | 0.000144052 |
| BBB | 0.471 |
| PPB | 0.191313 |
| VDSS | 0.435 |
| FU | 0.716831 |
| CYP1A2-inh | 0.014 |
| CYP1A2-sub | 0.055 |
| CYP2c19-inh | 0.024 |
| CYP2c19-sub | 0.405 |
| CYP2c9-inh | 0.003 |
| CYP2c9-sub | 0.559 |
| CYP2d6-inh | 0.003 |
| CYP2d6-sub | 0.188 |
| CYP3a4-inh | 0.006 |
| CYP3a4-sub | 0.033 |
| CL | 1.467 |
| T12 | 0.631 |
| hERG | 0.009 |
| Ames | 0.618 |
| ROA | 0.125 |
| SkinSen | 0.402 |
| Carcinogencity | 0.737 |
| EI | 0.009 |
| Respiratory | 0.04 |
| NR-Aromatase | 0.015 |
| Antiviral | No |
| Prediction | 0.598482 |